Emerging as a significant breakthrough in the fight against obesity, this medication is generating considerable attention . This treatment combines effects of two known GLP-1 binding agonists, dulaglutide , with an additional glucose-dependent peptide component. Initial study findings have demonstrated significant body reduction in people with exce